Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients - Wener, K M; Schechner, V; Gold, H S (Antimicrob Agents Chemother, 2010)
et al.